Status:
COMPLETED
Fluoxetine as a Quit Smoking AID for Depression Prone
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Cardiovascular Diseases
Heart Diseases
Eligibility:
All Genders
Up to 100 years
Phase:
NA
Brief Summary
To test whether adding fluoxetine pharmacotherapy to behavioral cessation treatment improves the depression-prone smoker's ability to quit.
Detailed Description
DESIGN NARRATIVE: The research was a treatment-matching study to test whether adding fluoxetine pharmacotherapy to behavioral cessation treatment improved the depression-prone smoker's ability to qui...
Eligibility Criteria
Inclusion
- An estimated 144 smokers with a prior history of depression and 206 smokers who lacked such a history.
Exclusion
Key Trial Info
Start Date :
February 1 1998
Trial Type :
INTERVENTIONAL
End Date :
January 1 2002
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00113737
Start Date
February 1 1998
End Date
January 1 2002
Last Update
February 18 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.